1973 related articles for article (PubMed ID: 19875727)
41. von Willebrand factor without the A2 domain is resistant to proteolysis.
Lankhof H; Damas C; Schiphorst ME; Ijsseldijk MJ; Bracke M; Furlan M; Tsai HM; de Groot PG; Sixma JJ; Vink T
Thromb Haemost; 1997 May; 77(5):1008-13. PubMed ID: 9184419
[TBL] [Abstract][Full Text] [Related]
42. The membrane-proximal intermolecular disulfide bonds in glycoprotein Ib influence receptor binding to von Willebrand factor.
Mo X; Luo SZ; Munday AD; Sun W; Berndt MC; López JA; Dong JF; Li R
J Thromb Haemost; 2008 Oct; 6(10):1789-95. PubMed ID: 18647229
[TBL] [Abstract][Full Text] [Related]
43. The A/T1381 polymorphism in the A1-domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein Ibalpha.
Szántó T; Schlammadinger A; Staelens S; De Meyer SF; Freson K; Pareyn I; Vauterin S; Hársfalvi J; Deckmyn H; Vanhoorelbeke K
Thromb Haemost; 2007 Jul; 98(1):178-85. PubMed ID: 17598011
[TBL] [Abstract][Full Text] [Related]
44. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
[TBL] [Abstract][Full Text] [Related]
45. [A mutation of platelet glycoprotein I balpha results in defects in its interaction with immobilized vWF].
Dong J; Li C; Schade AJ; Sun L; McIntire LV; Lopez JA
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):453-6. PubMed ID: 11877016
[TBL] [Abstract][Full Text] [Related]
46. Antithrombotic effect of a protein-type I class snake venom metalloproteinase, kistomin, is mediated by affecting glycoprotein Ib-von Willebrand factor interaction.
Hsu CC; Wu WB; Chang YH; Kuo HL; Huang TF
Mol Pharmacol; 2007 Oct; 72(4):984-92. PubMed ID: 17609416
[TBL] [Abstract][Full Text] [Related]
47. A novel missense mutation shows that GPIbbeta has a dual role in controlling the processing and stability of the platelet GPIb-IX adhesion receptor.
Strassel C; Pasquet JM; Alessi MC; Juhan-Vague I; Chambost H; Combrié R; Nurden P; Bas MJ; De La Salle C; Cazenave JP; Lanza F; Nurden AT
Biochemistry; 2003 Apr; 42(15):4452-62. PubMed ID: 12693941
[TBL] [Abstract][Full Text] [Related]
48. Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX-von willebrand factor interaction.
Mistry N; Cranmer SL; Yuan Y; Mangin P; Dopheide SM; Harper I; Giuliano S; Dunstan DE; Lanza F; Salem HH; Jackson SP
Blood; 2000 Nov; 96(10):3480-9. PubMed ID: 11071645
[TBL] [Abstract][Full Text] [Related]
49. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
50. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
Martin C; Morales LD; Cruz MA
J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
[TBL] [Abstract][Full Text] [Related]
51. Structure-function relationship of the A1 domain of von Willebrand factor.
Girma JP; Ribba AS; Meyer D
Thromb Haemost; 1995 Jul; 74(1):156-60. PubMed ID: 8578449
[TBL] [Abstract][Full Text] [Related]
52. Functional expression of single chain glycoprotein Ib alpha on the surface of COS cells and BHK cells.
Petersen EJ; Posthumus E; Sixma JJ
Thromb Haemost; 1996 Nov; 76(5):768-73. PubMed ID: 8950788
[TBL] [Abstract][Full Text] [Related]
53. Molecular genetics of von Willebrand disease.
Mazurier C; Ribba AS; Gaucher C; Meyer D
Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
[TBL] [Abstract][Full Text] [Related]
54. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates.
Kumar RA; Dong JF; Thaggard JA; Cruz MA; López JA; McIntire LV
Biophys J; 2003 Dec; 85(6):4099-109. PubMed ID: 14645097
[TBL] [Abstract][Full Text] [Related]
55. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.
Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R
Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169
[TBL] [Abstract][Full Text] [Related]
56. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D
Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886
[TBL] [Abstract][Full Text] [Related]
57. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.
Cauwenberghs N; Vanhoorelbeke K; Vauterin S; Westra DF; Romo G; Huizinga EG; Lopez JA; Berndt MC; Harsfalvi J; Deckmyn H
Blood; 2001 Aug; 98(3):652-60. PubMed ID: 11468163
[TBL] [Abstract][Full Text] [Related]
58. The snake venom protein botrocetin acts as a biological brace to promote dysfunctional platelet aggregation.
Fukuda K; Doggett T; Laurenzi IJ; Liddington RC; Diacovo TG
Nat Struct Mol Biol; 2005 Feb; 12(2):152-9. PubMed ID: 15665869
[TBL] [Abstract][Full Text] [Related]
59. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor.
Hilbert L; Jenkins PV; Gaucher C; Meriane E; Collins PW; Pasi KJ; Mazurier C
Thromb Haemost; 2000 Aug; 84(2):188-94. PubMed ID: 10959688
[TBL] [Abstract][Full Text] [Related]
60. Molecular genetic analysis of a variant Bernard-Soulier syndrome due to compound heterozygosity for two novel glycoprotein Ibbeta mutations.
Kunishima S; Sako M; Yamazaki T; Hamaguchi M; Saito H
Eur J Haematol; 2006 Dec; 77(6):501-12. PubMed ID: 16978236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
